<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Addict Med</journal-id><journal-id journal-id-type="iso-abbrev">J Addict Med</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Journal of addiction medicine</journal-title></journal-title-group><issn pub-type="ppub">1932-0620</issn><issn pub-type="epub">1935-3227</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10123169</article-id><article-id pub-id-type="pmcid-ver">PMC10123169.1</article-id><article-id pub-id-type="pmcaid">10123169</article-id><article-id pub-id-type="pmcaiid">10123169</article-id><article-id pub-id-type="manuscript-id">NIHMS1838361</article-id><article-id pub-id-type="pmid">37267172</article-id><article-id pub-id-type="doi">10.1097/ADM.0000000000001103</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1838361</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1838361</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Use of video directly-observed therapy and characteristics associated with use among patients treated with buprenorphine in an office-based setting</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Radick</surname><given-names initials="AC">Andrea C.</given-names></name><degrees>MS</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>James</surname><given-names initials="J">Jocelyn</given-names></name><degrees>MD</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Leroux</surname><given-names initials="BG">Brian G.</given-names></name><degrees>PhD</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kim</surname><given-names initials="TW">Theresa W.</given-names></name><degrees>MD</degrees><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Saxon</surname><given-names initials="AJ">Andrew J.</given-names></name><degrees>MD</degrees><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Samet</surname><given-names initials="JH">Jeffrey H.</given-names></name><degrees>MD, MA, MPH</degrees><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tsui</surname><given-names initials="JI">Judith I.</given-names></name><degrees>MD, MPH</degrees><xref rid="A1" ref-type="aff">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of General Internal Medicine, Department of Medicine, University of Washington, Seattle, WA</aff><aff id="A2"><label>2</label>Department of Biostatistics, University of Washington, Seattle WA, USA</aff><aff id="A3"><label>3</label>Clinical Addiction Research and Education (CARE) Unit, Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine and Boston Medical Center Boston, MA, USA</aff><aff id="A4"><label>4</label>Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA</aff><author-notes><corresp id="CR1"><bold>Corresponding author</bold>, Judith Tsui, MD MPH, Associate Professor, Department of Medicine, Division of General Internal Medicine, University of Washington/Harborview Medical Center, 325 9th Avenue, Box 359780, Seattle, WA 98104, <email>tsuij@uw.edu</email>, (206) 744-1835</corresp></author-notes><pub-date pub-type="ppub"><season>May-Jun</season><year>2023</year></pub-date><pub-date pub-type="epub"><day>25</day><month>10</month><year>2022</year></pub-date><volume>17</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">434101</issue-id><fpage>300</fpage><lpage>304</lpage><pub-history><event event-type="nihms-submitted"><date><day>21</day><month>10</month><year>2022</year></date></event><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>01</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 11:25:31.053"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1838361.pdf"/><abstract id="ABS1"><sec id="S1"><title>Objectives:</title><p id="P1">Video directly-observed therapy (video DOT) is a tool for confirming buprenorphine adherence that could complement the use of urine toxicology; research is needed to characterize the patients who are receptive and able to use this technology. We aimed to describe video DOT utilization and assess participant characteristics associated with use.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">Secondary analysis of data from a pilot randomized controlled trial of adults who recently initiated sublingual buprenorphine in office-based programs, restricting to intervention arm participants which consisted of 12 weeks of video DOT via a mobile health technology platform. Participants were instructed to record at least one daily video of buprenorphine self-administration. Poisson regression models with robust standard errors were used to measure associations between participant characteristics and frequency of submitted videos.</p></sec><sec id="S3"><title>Results:</title><p id="P3">Sample included 39 participants. Of 3,276 possible videos, 1,002 (31%) were submitted. Age &#8805;40 years (relative risk (RR)=2.54 (95% confidence interval (CI): 1.31&#8211;4.91)) and once daily buprenorphine dosing (RR=3.10 (95% CI: 1.76&#8211;5.48)) were positively associated with video submissions. Non-white race (RR=0.43 (95% CI: 0.19&#8211;0.97)), less than high school education (RR=0.27 (95% CI: 0.10&#8211;0.74)), history of previous buprenorphine treatment (RR=0.50 (95% CI: 0.25 &#8211; 0.97)), and &#8805;3 previous treatment attempts (RR=0.16 (95% CI: 0.07&#8211;0.37)) were negatively associated.</p></sec><sec id="S4"><title>Conclusion:</title><p id="P4">Video DOT utilization resulted in about a third of expected videos, although there were differences in use according to age, race, buprenorphine treatment factors and educational status. Such differences underscore that mobile-health interventions such as video DOT may not be equally utilized by all patients.</p></sec></abstract><kwd-group><kwd>directly-observed therapy</kwd><kwd>buprenorphine</kwd><kwd>opioid related disorders</kwd><kwd>mobile health (mHealth)</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>